Trader: Low Volume ...
Health Care: Health Services
Alcon Inc. (ACL: NYSE)
$167.99 -0.35 | -0.21%
04/08/11 - 04:00 PM ET
Latest Dividend:3.40
Latest Dividend Yield:2.02%
Dividend Ex-Date:05/24/10
Price Earnings Ratio:23.11
Price Earnings Comparisons:
| ACL | Sector Avg. | S&P 500 |
|---|---|---|
| 23.11 | 23.10 | 16.40 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 3.14 | 5.11 | 10.95 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 10.50 | 0.28 | 0.09 |
| Net Income | 10.10 | 0.39 | 0.12 |
| EPS | 9.20 | 0.38 | 0.11 |
Earnings for ACL:
| EBITDA | 2.75B |
| REVENUE | 7.18B |
Average Earnings Estimates
| Qtr (03/11) | Qtr (06/11) | FY (12/11) | FY (12/12) | |
|---|---|---|---|---|
| Average Estimate | $2.00 | $2.30 | $8.48 | $9.45 |
| Number of Analysts | 4 | 4 | 7 | 5 |
| High Estimate | $2.05 | $2.36 | $8.85 | $10.00 |
| Low Estimate | $1.94 | $2.20 | $8.33 | $9.21 |
| Prior Year | $1.91 | $2.22 | $7.71 | $8.48 |
| Growth Rate (Year over Year) | 4.71% | 3.38% | 9.97% | 11.41% |
Portfolios with ACL
- Portfolio NameUser Type
- ProMichael Price - MFP Investors
- User30 or Less
- Contributor4 Best Holdings in Harvard'...
- Contributor10 Stocks That Matter Most ...
- Contributor10 Stocks Favored by Hedge ...
- ContributorFour Stocks Liked by the Bi...
- Contributor10 Top Hedge Fund Buys
- ContributorStocks Third Point is Buyin...
- UserHelios 1
- ContributorRocket Stocks for the Week ...
Latest ACL Headlines from TheStreet
- Novartis Profit Falls 4%, Sales Rise 16% 04.19.11 | 04:04 am
- Stocks Under $10: Stealth Growth Play
04.12.11 | 12:04 pm - 4 Best Holdings in Harvard's Portfolio 03.10.11 | 09:03 am
- Nestle Profits Get Boost From Alcon Sale 02.17.11 | 04:02 am
- 5 Drug Stocks With Upside Potential of 25% 01.20.11 | 10:01 am
- 10 Stocks Favored by Hedge Funds 01.07.11 | 10:01 am
- Ryder, Novartis, Hertz, Dynegy Are Big Movers 12.15.10 | 04:12 pm
- Stock Futures Dip on Spain Rating Warning 12.15.10 | 08:12 am
- First Solar, Dynegy: Premarket Trading 12.15.10 | 08:12 am
- Novartis Buys Rest of Alcon Stake for $12.9B 12.15.10 | 03:12 am
Press Releases for ACL
- Anthony Clark- Normal Course Issuer Bid - Business Wire 05.15.12 | 12:05 pm
- Dr. Reddy’s Announces The USFDA Approval Of Fondaparinux Sodium Injection - Business Wire 07.13.11 | 01:07 am
- Anthony Clark - Issuance Of Shares For Bonuses - Business Wire 07.11.11 | 08:07 pm
- Anthony Clark – Dismissal Of Bankruptcy Adversary Proceeding Complaint By Brooke Trustee On U.S. Subsidiaries - Business Wire 06.13.11 | 07:06 pm
- Anthony Clark Announces Sale Of Southern California Agency - Business Wire 06.08.11 | 07:06 pm
- Anthony Clark - Normal Course Issuer Bid - Business Wire 05.16.11 | 07:05 pm
- Alcon Shareholders Approve Merger With Novartis - Business Wire 04.07.11 | 04:04 pm
- Alcon Files Form 20-F With U.S. Securities And Exchange Commission - Business Wire 03.18.11 | 06:03 pm
- Alcon Announces Date Of Annual General Meeting - Business Wire 02.28.11 | 01:02 am
- Anthony Clark-Issuance Of Shares For Debt - Business Wire 02.11.11 | 12:02 pm
Partner Headlines for ACL
- Novartis Drug Approval Delayed - Analyst Blog - Zacks 03.25.11 | 07:03 pm
- 4 Picks for the Healthcare Rebound - Seeking Alpha 03.24.11 | 09:03 am
- NVS' Lucentis Gets EU Backing - Analyst Blog - Zacks 03.23.11 | 10:03 am
- Mixed Opinion on NVS Lung Drug - Analyst Blog - Zacks 03.10.11 | 08:03 pm
- Alcon, Inc. - Growth & Income - Zacks 02.24.11 | 01:02 am
- John Paulson's 20 Largest Holdings and Recent Performance - Seeking Alpha 02.22.11 | 09:02 am
- Novartis to Buy Genoptix - Analyst Blog - Zacks 01.28.11 | 09:01 am
- Thomas Steyer's Winning Hedge Fund Holdings - Seeking Alpha 01.23.11 | 06:01 am
- A Big Week for Earnings - Seeking Alpha 01.21.11 | 05:01 pm
- 20 Underperforming Stocks With a Track Record of Profitability - Seeking Alpha 01.14.11 | 06:01 am
